Raab & Moskowitz Asset Management LLC Sells 200 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Raab & Moskowitz Asset Management LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,723 shares of the healthcare conglomerate’s stock after selling 200 shares during the quarter. UnitedHealth Group comprises approximately 1.0% of Raab & Moskowitz Asset Management LLC’s portfolio, making the stock its 26th biggest position. Raab & Moskowitz Asset Management LLC’s holdings in UnitedHealth Group were worth $3,907,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter worth $30,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth about $37,000. Friedenthal Financial purchased a new stake in UnitedHealth Group during the 3rd quarter valued at about $51,000. Highline Wealth Partners LLC purchased a new position in UnitedHealth Group in the third quarter worth about $55,000. Finally, Legacy Investment Solutions LLC purchased a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $57,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have commented on UNH shares. Wells Fargo & Company cut their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Truist Financial reduced their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft raised their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $527.31 on Thursday. The stock has a market cap of $485.27 billion, a PE ratio of 34.02, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a fifty day moving average price of $526.25 and a 200-day moving average price of $563.96. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter last year, the business posted $5.83 earnings per share. The firm’s revenue was up 6.8% on a year-over-year basis. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.